Cargando…
Prenatal genetic diagnosis: fetal therapy as a possible solution to a positive test
BACKGROUND: Fetal abnormalities cause 20% of perinatal deaths. Advances in prenatal genetic and other types of screening offer great opportunities for identifying high risk pregnancies. METHODS: Through a literature search, here we summarise what are the prenatal diagnostic technique that are being...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023142/ https://www.ncbi.nlm.nih.gov/pubmed/33170180 http://dx.doi.org/10.23750/abm.v91i13-S.10534 |
_version_ | 1783675072295206912 |
---|---|
author | Kiani, Aysha Karim Paolacci, Stefano Scanzano, Pietro Michelini, Sandro Capodicasa, Natale D’Agruma, Leonardo Notarangelo, Angelantonio Tonini, Gerolamo Piccinelli, Daniela Farshid, Kalantary Rad Petralia, Paolo Fulcheri, Ezio Buffelli, Francesca Chiurazzi, Pietro Terranova, Corrado Plotti, Francesco Angioli, Roberto Castori, Marco Pös, Ondrej Szemes, Tomas Bertelli, Matteo |
author_facet | Kiani, Aysha Karim Paolacci, Stefano Scanzano, Pietro Michelini, Sandro Capodicasa, Natale D’Agruma, Leonardo Notarangelo, Angelantonio Tonini, Gerolamo Piccinelli, Daniela Farshid, Kalantary Rad Petralia, Paolo Fulcheri, Ezio Buffelli, Francesca Chiurazzi, Pietro Terranova, Corrado Plotti, Francesco Angioli, Roberto Castori, Marco Pös, Ondrej Szemes, Tomas Bertelli, Matteo |
author_sort | Kiani, Aysha Karim |
collection | PubMed |
description | BACKGROUND: Fetal abnormalities cause 20% of perinatal deaths. Advances in prenatal genetic and other types of screening offer great opportunities for identifying high risk pregnancies. METHODS: Through a literature search, here we summarise what are the prenatal diagnostic technique that are being used and how those techniques may allow for prenatal interventions. RESULTS: Next generation sequencing and non-invasive prenatal testing are fundamental for clinical diagnostics because of their sensitivity and accuracy in identifying point mutations, aneuploidies, and microdeletions, respectively. Timely identification of genetic disorders and other fetal abnormalities enables early intervention, such as in-utero gene therapy, fetal drug therapy and prenatal surgery. CONCLUSION: Prenatal intervention is mainly focused on conditions that may cause death or lifelong disabilities, like spina bifida, congenital diaphragm hernia and sacrococcygeal teratoma; and may be an alternative therapeutic option to termination of pregnancy. However, it is not yet widely available, due to lack of specialized centers. (www.actabiomedica.it) |
format | Online Article Text |
id | pubmed-8023142 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Mattioli 1885 |
record_format | MEDLINE/PubMed |
spelling | pubmed-80231422021-04-07 Prenatal genetic diagnosis: fetal therapy as a possible solution to a positive test Kiani, Aysha Karim Paolacci, Stefano Scanzano, Pietro Michelini, Sandro Capodicasa, Natale D’Agruma, Leonardo Notarangelo, Angelantonio Tonini, Gerolamo Piccinelli, Daniela Farshid, Kalantary Rad Petralia, Paolo Fulcheri, Ezio Buffelli, Francesca Chiurazzi, Pietro Terranova, Corrado Plotti, Francesco Angioli, Roberto Castori, Marco Pös, Ondrej Szemes, Tomas Bertelli, Matteo Acta Biomed Original Article BACKGROUND: Fetal abnormalities cause 20% of perinatal deaths. Advances in prenatal genetic and other types of screening offer great opportunities for identifying high risk pregnancies. METHODS: Through a literature search, here we summarise what are the prenatal diagnostic technique that are being used and how those techniques may allow for prenatal interventions. RESULTS: Next generation sequencing and non-invasive prenatal testing are fundamental for clinical diagnostics because of their sensitivity and accuracy in identifying point mutations, aneuploidies, and microdeletions, respectively. Timely identification of genetic disorders and other fetal abnormalities enables early intervention, such as in-utero gene therapy, fetal drug therapy and prenatal surgery. CONCLUSION: Prenatal intervention is mainly focused on conditions that may cause death or lifelong disabilities, like spina bifida, congenital diaphragm hernia and sacrococcygeal teratoma; and may be an alternative therapeutic option to termination of pregnancy. However, it is not yet widely available, due to lack of specialized centers. (www.actabiomedica.it) Mattioli 1885 2020 2020-11-09 /pmc/articles/PMC8023142/ /pubmed/33170180 http://dx.doi.org/10.23750/abm.v91i13-S.10534 Text en Copyright: © 2020 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA http://creativecommons.org/licenses/by-nc-sa/4.0 This work is licensed under a Creative Commons Attribution 4.0 International License |
spellingShingle | Original Article Kiani, Aysha Karim Paolacci, Stefano Scanzano, Pietro Michelini, Sandro Capodicasa, Natale D’Agruma, Leonardo Notarangelo, Angelantonio Tonini, Gerolamo Piccinelli, Daniela Farshid, Kalantary Rad Petralia, Paolo Fulcheri, Ezio Buffelli, Francesca Chiurazzi, Pietro Terranova, Corrado Plotti, Francesco Angioli, Roberto Castori, Marco Pös, Ondrej Szemes, Tomas Bertelli, Matteo Prenatal genetic diagnosis: fetal therapy as a possible solution to a positive test |
title | Prenatal genetic diagnosis: fetal therapy as a possible solution to a positive test |
title_full | Prenatal genetic diagnosis: fetal therapy as a possible solution to a positive test |
title_fullStr | Prenatal genetic diagnosis: fetal therapy as a possible solution to a positive test |
title_full_unstemmed | Prenatal genetic diagnosis: fetal therapy as a possible solution to a positive test |
title_short | Prenatal genetic diagnosis: fetal therapy as a possible solution to a positive test |
title_sort | prenatal genetic diagnosis: fetal therapy as a possible solution to a positive test |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023142/ https://www.ncbi.nlm.nih.gov/pubmed/33170180 http://dx.doi.org/10.23750/abm.v91i13-S.10534 |
work_keys_str_mv | AT kianiayshakarim prenatalgeneticdiagnosisfetaltherapyasapossiblesolutiontoapositivetest AT paolaccistefano prenatalgeneticdiagnosisfetaltherapyasapossiblesolutiontoapositivetest AT scanzanopietro prenatalgeneticdiagnosisfetaltherapyasapossiblesolutiontoapositivetest AT michelinisandro prenatalgeneticdiagnosisfetaltherapyasapossiblesolutiontoapositivetest AT capodicasanatale prenatalgeneticdiagnosisfetaltherapyasapossiblesolutiontoapositivetest AT dagrumaleonardo prenatalgeneticdiagnosisfetaltherapyasapossiblesolutiontoapositivetest AT notarangeloangelantonio prenatalgeneticdiagnosisfetaltherapyasapossiblesolutiontoapositivetest AT toninigerolamo prenatalgeneticdiagnosisfetaltherapyasapossiblesolutiontoapositivetest AT piccinellidaniela prenatalgeneticdiagnosisfetaltherapyasapossiblesolutiontoapositivetest AT farshidkalantaryrad prenatalgeneticdiagnosisfetaltherapyasapossiblesolutiontoapositivetest AT petraliapaolo prenatalgeneticdiagnosisfetaltherapyasapossiblesolutiontoapositivetest AT fulcheriezio prenatalgeneticdiagnosisfetaltherapyasapossiblesolutiontoapositivetest AT buffellifrancesca prenatalgeneticdiagnosisfetaltherapyasapossiblesolutiontoapositivetest AT chiurazzipietro prenatalgeneticdiagnosisfetaltherapyasapossiblesolutiontoapositivetest AT terranovacorrado prenatalgeneticdiagnosisfetaltherapyasapossiblesolutiontoapositivetest AT plottifrancesco prenatalgeneticdiagnosisfetaltherapyasapossiblesolutiontoapositivetest AT angioliroberto prenatalgeneticdiagnosisfetaltherapyasapossiblesolutiontoapositivetest AT castorimarco prenatalgeneticdiagnosisfetaltherapyasapossiblesolutiontoapositivetest AT posondrej prenatalgeneticdiagnosisfetaltherapyasapossiblesolutiontoapositivetest AT szemestomas prenatalgeneticdiagnosisfetaltherapyasapossiblesolutiontoapositivetest AT bertellimatteo prenatalgeneticdiagnosisfetaltherapyasapossiblesolutiontoapositivetest |